JNJ Stock Edges Up After-Hours On Apollo’s $20B Orthopedics Talks
People familiar with the discussions told Bloomberg that Apollo is working toward a valuation of close to $20 billion for the unit, known as DePuy Synthes. The talks remain private and may not produce a transaction, Bloomberg said. J&J announced in October 2025 that it intends to separate the orthopedics business. At the Wells Fargo … Read more